CX26 promotes pancreatic cancer progression by competitively inhibiting interaction of c-Myc with PSMD2 and enhancing c-Myc stability
Abstract Background Pancreatic cancer (PC) is highly aggressive and fatal and has dismal prognostic outcomes, primarily due to its late-stage diagnosis and limited effective treatments. The molecular mechanisms triggering PC progression are largely unclear. This study investigated how CX26 contribut...
Saved in:
| Main Authors: | Cheng He, Chuanyu Tang, Jie Guo, Xiangyi Yin, Qing Zhu, Chihua Fang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06983-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PSMD11 and PSMD14 may serve as novel biomarkers for the prognosis of pancreatic ductal adenocarcinoma
by: Yan-Hui Yang, et al.
Published: (2025-03-01) -
WDR26-related Skraban–Deardorff syndrome: clinical, genetic and pathomechanistic insights
by: Xueqin Lin, et al.
Published: (2025-08-01) -
A Potential Role for c-MYC in the Regulation of Meibocyte Cell Stress
by: Isabella Boyack, et al.
Published: (2025-05-01) -
Collaboration of Hprt/K-RAS/c-Myc mutation in the oncogenesis of T-lymphocytic leukemia: a comparative study
by: Mai O Kadry, et al.
Published: (2024-12-01) -
JS-K induces ferroptosis in renal carcinoma cells by regulating the c-Myc-GSTP1 Axis
by: Yuwan Zhao, et al.
Published: (2025-05-01)